Navigation Links
Researchers Find Gene Mutation That Increases Asthma Risk
Date:4/9/2008

Study finds variant and protein it expresses may cause some cases of the disease

WEDNESDAY, April 9 (HealthDay News) -- Just a small change in one gene, called CHI3L1, can increase a person's risk of developing asthma.

The genetic variation in CHI3L1 causes the gene to release high levels of a protein known as YKL-40, and high levels of this protein have been associated with an increased risk of asthma in past research. The current study found that high levels of YKL-40 in four different population groups were linked to the development of asthma in all four groups, suggesting that YKL-40 and CHI3L1 are likely at the root of some cases of asthma.

That means if scientists can block YKL-40, they could create a novel, potentially more effective treatment for people with asthma.

"While there won't be one silver bullet for all asthma, we can start to think about tailoring medications to get at the cause, rather than just alleviating asthma symptoms," said study author Carole Ober, a professor of human genetics at the University of Chicago. "These findings give us optimism that one day there will be better treatments, more targeted to the specific cause of asthma."

The findings were published online April 9 by the New England Journal of Medicine and were expected to be in the journal's April 17 print issue.

It's believed that YKL-40 was originally produced by the body as a defensive mechanism against harmful parasitic worms, called helminths, according to Dr. Burton Dickey, chairman of pulmonary medicine at M.D. Anderson Cancer Center in Houston. Dickey said that helminths contained a substance called chitin that is also found in fungi, crustaceans and in insects such as dust mites and cockroaches. YKL-40 is what's known as a chitinase-like protein, because it attaches itself to chitin, possibly alerting the body that chitins are present.

But, Dickey pointed out that in the developed
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Researchers Define Mechanism of Methamphetamine Addiction
2. Attacks against medical researchers: Time to take a stand
3. Researchers Able to Continue their Work to Help Patients Thanks to McDevitt Excellence in Research Awards from Blue Cross Blue Shield of Michigan Foundation
4. More genes for Lou Gehrigs disease identified, according to Penn researchers
5. Clinical trial volunteers mostly indifferent -- but not blind to -- researchers financial conflicts
6. Researchers learn how signaling molecule orchestrates breast cancers spread
7. Researchers ID gene linked to lung cancer
8. USC researchers find new clues to risk of Hodgkin lymphoma
9. Researchers develop new method to test for lung cancer
10. UCLA researchers design nanomachine that kills cancer cells
11. Researchers study why high school boys dodge Phys Ed

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers Find Gene Mutation That Increases Asthma Risk
Researchers Find Gene Mutation That Increases Asthma Risk
(Date:11/30/2009)...e bills stack up , , MONDAY, Nov. 30 (He...g through the U.S. Congress differ in a number of ...on in the number of uninsured Americans. , Legi...arlier this month would expand coverage to 96 perc...e a proposal to expand coverage to 94 percent of A...
(Date:11/30/2009)...about a stocking stuffer that saves lives? Holiday...tive POP BANDS® , Pet Collars and Leashes bec... fun gifts that make a difference. , ...-- How would you like to give a gift this holiday ..., ,Vedante,s super-reflective POP BANDS® made ...
(Date:11/30/2009)... uses Staten Island courtroom to recreate scene of...% responsible for client’s accident. , ...r 30, 2009 -- A Staten Island, N.Y. jury awarded a...er who was injured at a New York City construction...gen Construction Company et al (Index No. 102557/0...
(Date:11/30/2009)...d PLYMOUTH MEETING, Pa., Nov. 30 T...announced that it has signed an agreement with ECR...r its academic medical center members special pric...ch. This agreement will offer UHC members current ..., an independent nonprofit organization, is a lead...
(Date:11/30/2009)...a study revealed that beverage can pull-tabs were ... U.S. manufacturers to stay-tabs. But a study pres...cal Society of North America (RSNA) found that the...f the driving factors leading the change in bevera...nadvertent swallowing of the pull-tab and potentia...
Breaking Medicine News(10 mins):Health News:Health Reform: What's in It for You? 2Health News:Health Reform: What's in It for You? 3Health News:Fun and Fashionable Holiday Gifts that Save Lives 2Health News:Fun and Fashionable Holiday Gifts that Save Lives 3Health News:Fun and Fashionable Holiday Gifts that Save Lives 4Health News:Raphaelson & Levine Secures $1.1 Million Verdict for Victim of New York Construction Accident 2Health News:University HealthSystem Consortium and ECRI Institute(R) to Provide Enhanced Health Technology Assessment Services 2Health News:University HealthSystem Consortium and ECRI Institute(R) to Provide Enhanced Health Technology Assessment Services 3Health News:Beverage can stay-tabs pose swallowing risk 2
...chester Medical Center (URMC) announced today that... developer and philanthropist Richard T. Fields fo...largest private donation for a specific disease pr...cular dystrophy. , The new Fields Center for FSHD...
...he University of Michigan is the lead research ins...tium to study the health consequences on victims i...al Center for Disaster Mental Health Research, inc... is funded by the National Institutes of Health. ,...
...r blow to Trasylol, used to cut down on bleeding d...5 (HealthDay News) -- The U.S. Food and Drug Admin...ty of the clotting drug aprotinin (Trasylol), afte... the FDA in 1993, is typically used to limit blood...
...ME (BioMedical Enterprises, Inc.),today announced ... Medical,Director, was elected to BME,s Board of D...excelled in his leadership as,Medical Director of ...e to the BOD over this year has demonstrated,his i...
...venue, Net Income and EPS; Revenue, Net...., Oct. 25 MICROS Systems, Inc.,(Nasdaq: MCRS ),...hospitality and retail industries, today announced...rease of $42.8 million, or 24.6%, over the sam...
...s to switch the wrigglers, orientation , THURSDAY,...hard-wired into the brains of small worms called n...ed some of the creatures to make them attracted to...y are about worms and how attraction behaviors are...
Other Medicine News:Health News:New center to lead international muscular dystrophy research effort 2Health News:New center to lead international muscular dystrophy research effort 3Health News:New center to lead international muscular dystrophy research effort 4Health News:U-M to lead disaster aftermath research center 2Health News:FDA to Review Clotting Drug After Trial Suggests Death Risk 2Health News:FDA to Review Clotting Drug After Trial Suggests Death Risk 3Health News:FDA to Review Clotting Drug After Trial Suggests Death Risk 4Health News:MICROS Reports Fiscal 2008 First Quarter Results 2Health News:MICROS Reports Fiscal 2008 First Quarter Results 3Health News:MICROS Reports Fiscal 2008 First Quarter Results 4Health News:MICROS Reports Fiscal 2008 First Quarter Results 5Health News:MICROS Reports Fiscal 2008 First Quarter Results 6Health News:MICROS Reports Fiscal 2008 First Quarter Results 7Health News:Worm Study Points to Sexuality's Origins 2
(Date:11/30/2009)..., , RICHMOND, Va., Nov. 30 ...cense with sanofi-aventis U.S. for a novel epineph...ry. Under the license, sanofi-aventis U.S. shall b...ion. Intelliject will be responsible for the on-go...approval and has retained certain co-promotion rig...
(Date:11/30/2009)..., , BRIDGEWATER, N.J., Nov. 30 /PRNewswi...ay the signing of an exclusive licensing agreement...to injector for the emergency treatment of allergi...nd Canada). ,, "We are pleased to have this op... for the millions of people who are at risk of thi...
(Date:11/30/2009)..., , ATLANTA, Ge...ollege of,Direct Support (CDS), an internet-based ...naged in partnership by MC Strategies/Elsevier and...ning Center, announced today that,its second Disab...s now,available for administrators and learners to...
Breaking Medicine Technology:Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector 2Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector 3Sanofi-aventis U.S. and Intelliject, Inc. Sign Licensing Agreement for Novel Epinephrine Auto Injector in North America 2Sanofi-aventis U.S. and Intelliject, Inc. Sign Licensing Agreement for Novel Epinephrine Auto Injector in North America 3Cerebral Palsy Course Strengthens CDS Curriculum as Second Disability Intensive Course Offering 2Cerebral Palsy Course Strengthens CDS Curriculum as Second Disability Intensive Course Offering 3Wed Sept 16 11 AM News Conference 3A Sioux Falls Keystone Treatment Center Is National HQ to Lead 100 Locations Nationwide in Balloon Liftoff Cele 56666 1Wed Sept 16 11 AM News Conference 3A Sioux Falls Keystone Treatment Center Is National HQ to Lead 100 Locations Nationwide in Balloon Liftoff Cele 56666 2Bright Beginnings 28R 29 NeoCare 28TM 29 Value Priced Weight Gain Infant Formula Now Available Online at www pbmstore com 56662 1Bright Beginnings 28R 29 NeoCare 28TM 29 Value Priced Weight Gain Infant Formula Now Available Online at www pbmstore com 56662 2Testing Young Athletes for Heart Defects May Save Lives 56660 1Testing Young Athletes for Heart Defects May Save Lives 56660 2
...07-Preliminary results from,the immunotherapeutic ...nter show a very good safety profile for SBG. Furt...nt have been observed,among several patients that ... monoclonal antibody against neuroblastoma. , In l...report for,the 1st quarter 2007, all 24 patients h...
...ional Myeloma Workshop held in,Kos, Greece demonst...on with bortezomib, dexamethasone and lenalidomide...ractory multiple,myeloma, and as a single agent in...acroglobulinemia, NEW YORK, June 29, 2007 /PRNewsw...oday announced that 4 posters were,presented at th...
Other Medicine Technology:Biotec Pharmacon Announces Preliminary Results from the,Sloan-Kettering Clinical Study 2Biotec Pharmacon Announces Preliminary Results from the,Sloan-Kettering Clinical Study 3Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 2Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 3Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 4Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 5Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 6Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 7
... a new level of immunodiagnostic productivity. Opt...h any laboratory automation system. No-pause loadi...e only immunoassay system with this capability. No...thout any additional setup. Continuous sample load...
... random access operation, the Elecsys 2010 System ...ories that want to maximize productivity and effic...ity and Stat capabilities of the Elecsys 1010 syst...f an aggressive laboratory testing environment. It...
Dimension RxL Max w/o HM 50/60 HZ
Modular Analytics E 170 Module
Medicine Products: